NanoPass Technologies and Aesthetic Management Partners (AMP) have signed an agreement to begin commercializing NanoPass’s MicronJet 600 intradermal delivery device in the United States.
The aim of the collaboration is to provide dermatologists and aesthetic physicians with a safe, practically painless, shallow, and consistent intradermal delivery device to enable local anesthesia and treatment of thin skin, fine wrinkles and other sensitive locations with various substances for optimal results. NanoPass’s MicronJet 600, to be used for local anesthesia in conjunction with AMP’s portfolio of devices, provides a synergistic approach to aesthetic treatments that will maximize patient benefit and comfort.
NanoPass’s MicronJet 600 is an intradermal injection device with three 0.6mm, hollow, pyramid-shaped, microneedles. It is produced by NanoPass using MEMS technology from silicon crystal.
“We are incredibly excited to be working with NanoPass Technologies and the MicronJet 600. The attention to detail on this product is impressive. We look forward to seeing our partners maximize the use of this intradermal delivery device that will separate their practice from others.”
— Erik Dowell, CEO of Aesthetic Management Partners
“We are excited to enter this collaboration, which marks our entry into the US aesthetic market with AMP, an expert in providing high quality aesthetic devices. MicronJet 600 enables a reliable and nearly painless injection into the shallow skin. The microneedles do not penetrate deeper than the dermis, which is the main target of aesthetic treatments. We will continue to make strides into this market, as it cherishes innovation, reduction of pain and improved outcomes.”
— Yotam Levin, MD, CEO of NanoPass
[Source(s): NanoPass, AMP, PR Newswire]
